Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Non-Medical Switching Impact on Patients and Providers – Psoriatic Disease Community Taking a Stand

Non-Medical Switching Impact on Patients and Providers – Psoriatic Disease Community Taking a Stand Editorial Journal of Psoriasis and Psoriatic Arthritis 2021, Vol. 6(3) 126-127 ª The Author(s) 2021 Non-Medical Switching Impact on Patients Article reuse guidelines: sagepub.com/journals-permissions and Providers – Psoriatic Disease DOI: 10.1177/24755303211024205 journals.sagepub.com/home/jps Community Taking a Stand 1 2 April Armstrong, MD, MPH , Mark Lebwohl, MD , 3 4 Joseph F. Merola, MD, MMSc , Samantha Koons , 5 6 7 Richard Fried, MD, PhD , Jason Hawkes, MD, MS , John Koo, MD , 8 9 10 Richard Langley, MD , George Martin, MD , Soumya Reddy, MD , 11 12 Sergio Schwartzman, MD , Evan Siegel, MD , 13 14 Abby Van Voorhees, MD , Elizabeth Wallace, MD , 15 4 4 Jeffrey Weinberg, MD , Leah Howard, JD , and Stacie Bell, PhD Keywords psoriasis, psoriatic arthritis, health policy, insurance, biologics, chronic disease, systemic disease, management Non-medical switching (NMS) occurs when a payer mandates NMS can disrupt well-controlled disease. Studies have that patients switch therapies, either within or across therapeu- shown that, in patients with inflammatory diseases, NMS was tic classes, for non-medical reasons. This type of therapeutic associated with significantly worse clinical outcomes, includ- substitution can increase the disease burden and present safety ing increased http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Journal of Psoriasis and Psoriatic Arthritis SAGE

Non-Medical Switching Impact on Patients and Providers – Psoriatic Disease Community Taking a Stand

Download PDF
2 pages

Loading next page...
 
/lp/sage/non-medical-switching-impact-on-patients-and-providers-psoriatic-K4feE5wdAK

References (5)

Publisher
SAGE
Copyright
© The Author(s) 2021
ISSN
2475-5303
eISSN
2475-5311
DOI
10.1177/24755303211024205
Publisher site
See Article on Publisher Site

Abstract

Editorial Journal of Psoriasis and Psoriatic Arthritis 2021, Vol. 6(3) 126-127 ª The Author(s) 2021 Non-Medical Switching Impact on Patients Article reuse guidelines: sagepub.com/journals-permissions and Providers – Psoriatic Disease DOI: 10.1177/24755303211024205 journals.sagepub.com/home/jps Community Taking a Stand 1 2 April Armstrong, MD, MPH , Mark Lebwohl, MD , 3 4 Joseph F. Merola, MD, MMSc , Samantha Koons , 5 6 7 Richard Fried, MD, PhD , Jason Hawkes, MD, MS , John Koo, MD , 8 9 10 Richard Langley, MD , George Martin, MD , Soumya Reddy, MD , 11 12 Sergio Schwartzman, MD , Evan Siegel, MD , 13 14 Abby Van Voorhees, MD , Elizabeth Wallace, MD , 15 4 4 Jeffrey Weinberg, MD , Leah Howard, JD , and Stacie Bell, PhD Keywords psoriasis, psoriatic arthritis, health policy, insurance, biologics, chronic disease, systemic disease, management Non-medical switching (NMS) occurs when a payer mandates NMS can disrupt well-controlled disease. Studies have that patients switch therapies, either within or across therapeu- shown that, in patients with inflammatory diseases, NMS was tic classes, for non-medical reasons. This type of therapeutic associated with significantly worse clinical outcomes, includ- substitution can increase the disease burden and present safety ing increased

Journal

Journal of Psoriasis and Psoriatic Arthritis – SAGE

Published: Jul 1, 2021

Keywords: psoriasis; psoriatic arthritis; health policy; insurance; biologics; chronic disease; systemic disease; management

There are no references for this article.